Stem cell activity of porcine c-kit+ hematopoietic cells

Experimental Hematology

Volumn 31, Issue 9, 2003, Pages 833-840

  Le Guern, Annie C ^a   Giovino, Maria A ^b   Abe, Masahiro ^c   Theodore, Pierre R ^c   Qi, Jin ^c   Down, Julian D ^a   Sachs, David H ^c   Sykes, Megan ^c   Yang, Yong Guang ^c  

^a BioTransplant Inc   (United States)

^b Immerge Biotherapeutics Inc   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL; CELL ACTIVITY; CELL TRANSPLANTATION; CHIMERA; COLONY FORMING UNIT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUSE STRAIN; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PURIFICATION; RECIPIENT; STEM CELL; SWINE; TRANSGENE; TRANSGENIC MOUSE;

MUS MUSCULUS; SUIDAE;

EID: 0043238101     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(03)00197-8     Document Type: Article

References (48)

1. Bhatia M., Wang J.C.Y., Kapp U., Bonnet D., Dick J.E. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A. 94:1997;5320-5325.
2. Chang W.C., Fujimiya Y., Casteel N., Pattengale P. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia III. Defective interleukin-2 production by T-helper and natural killer cells . Int J Cancer. 43:1989;591-597.
3. low/negative hematopoietic stem cell. Science. 273:1996;242-245.
4. - cells in vivo. Ann N Y Acad Sci. 872:1999;220-231.
5. + bone marrow cells. Exp Hematol. 26:1998;440-448.
6. Goodell M.A., Rosenzweig M., Kim H., et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med. 3:1997;1337-1345.
7. Bhatia M., Bonnet D., Murdoch B., Gan O.I., Dick J.E. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med. 4:1998;1038-1045.
8. Sato T., Laver J.H., Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood. 94:1999;2548-2554.
9. - hematopoietic stem cells using cell surface markers AC133 and CD7. Blood. 95:2000;2813-2820.
10. Matsuoka S., Ebihara Y., Xu M., et al. CD34 expression on long-term repopulating hematopoietic stem cells changes during developmental stages. Blood. 97:2001;419-425.
11. Okuno Y., Iwasaki H., Huettner C.S., et al. Differential regulation of the human and murine CD34 genes in hematopoietic stem cells. Proc Natl Acad Sci U S A. 99:2002;6246-6251.
12. Ogawa M., Matsuzaki Y., Nishikawa S., et al. Expression and function of c-kit in hematopoietic progenitor cells. J Exp Med. 174:1991;63-71.
13. Ikuta K., Weissman I.L. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci U S A. 89:1992;1502-1506.
14. Orlic D., Fischer R., Nishikawa S.-I., Nienhuis A.W., Bodine D.M. Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. Blood. 82:1993;762-770.
15. Okada S., Nagayoshi H., Natauchi H., et al. Sequential analysis of hematopoietic reconstitution achieved by transplantation of hematopoietic stem cells. Blood. 81:1993;1720-1725.
16. Ortiz M., Wine J.W., Lohrey N., et al. Functional characterization of a novel hematopoietic stem cell and its place in the c-kit maturation pathway in bone marrow cell development. Immunity. 10:1999;173-182.
17. Sachs D.H. The pig as a xenograft donor. Pathol Biol (Paris). 42:1994;217-219.
18. Cooper D.K.C., Ye Y., Rolf L.L. Jr., Zuhdi N. The pig as potential organ donor for man. Cooper D.K.C., Kemp E., Reemtsma K., White D.J.G. Xenotransplantation. 1991;481-500 Springer-Verlag, Heidelberg.
19. + cells in mice expressing porcine cytokines: Toward tolerance induction across discordant xenogeneic barriers. Transplantation. 69:2000;2484-2490.
20. Sachs D.H. The pig as a potential xenograft. Vet Immunol Immunopath. 43:1999;187-193.
21. Pescovitz M.D., Lunney J.K., Sachs D.H. Preparation and characterization of monoclonal antibodies reactive with porcine PBL. J Immunol. 133:1984;368-375.
22. Hammerburg C., Schurig G. Characterization of monoclonal antibodies directed against swine leukocytes. Vet Immunol Immunopathol. 11:1986;107-121.
23. Zhao Y., Swenson K., Sergio J.J., et al. Skin graft tolerance across a discordant xenogeneic barrier. Nat Med. 2:1996;1211-1216.
24. Davis W.C., Marusic S., Lewin H.A., et al. The development and analysis of species specific and cross reactive monoclonal antibodies to leukocyte differentiation antigens and antigens of the major histocompatibility complex for use in the study of the immune system in cattle and other species. Vet Immunol Immunopathol. 15:1987;337-376.
25. Huang C.A., Lorf T., Arn J.S., et al. Characterization of a monoclonal anti-porcine CD3 antibody. Xenotransplantation. 6:1999;201-212.
26. Pescovitz M.D., Lunney J.K., Sachs D.H. Murine anti-swine T4 and T8 monoclonal antibodies: distribution and effects on proliferative and cytotoxic T cells. J Immunol. 134:1985;37-44.
27. Dato M.E., Wierda W.G., Kim Y.B. A triggering structure recognized by G7 monoclonal antibody on porcine lymphocytes and granulocytes. Cell Immuol. 140:1992;468-477.
28. Saalmuller A. Characterization of swine leukocyte differentiation antigens. Immunol Today. 17:1996;352-354.
29. Pescovitz M.D., Book B.K., Aasted B., et al. Summary of workshop findings for antibodies reacting with porcine T-cells and activation antigens: results from the Second International Swine CD Workshop. Vet Immunol Immunopathol. 60:1998;251-260.
30. Unkeless J.C. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med. 150:1979;580-596.
31. Ploemacher R.E., van der Sluijs J.P., Voerman J.S., Brons N.H. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood. 74:1989;2755-2763.
32. Breems D.A., Blokland E.A., Neben S., Ploemacher R.E. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia. 8:1994;1095-1104.
33. Buhler L., Awwad M., Treter S., et al. Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockade 1. Transplantation. 73:2002;12-22.
34. Fazekas de St Groth B. The evaluation of limiting dilution assays. J Immunol Methods. 49:1982;R11-R23.
35. Okada S., Nakauchi H., Nagayoshi K., et al. Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood. 78:1991;1706-1712.
36. de Jong M.O., Wagemaker G., Wognum A.W. Separation of myeloid and erythroid progenitors based on expression of CD34 and c-kit. Blood. 86:1995;4076-4085.
37. Huss R., Hong D.S., McSweeney P.A., Hoy C.A., Deeg H.J. Differentiation of canine bone marrow cells with hemopoietic characteristics from an adherent stromal cell precursor. Proc Natl Acad Sci U S A. 92:1995;748-752.
38. Ody C., Corbel C., Dunon D., Vainio O., Imhof B.A. MHC class II and c-kit expression allows rapid enrichment of T-cell progenitors from total bone marrow cells. Blood. 96:2000;3988-3990.
39. Korsgren O. Acute cellular xenograft rejection. Xenotransplantation. 4:1997;11-19.
40. Mandel T.E., Kavorik J., Koulmanda M., Georgiou H.M. Cellular rejection of fetal pancreas grafts: Differences between allo- and xenograft rejection. Xenotransplantation. 4:1997;2-10.
41. Ildstad S.T., Sachs D.H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature. 307:1984;168-170.
42. Sharabi Y., Aksentijevich I., Sundt T.M. III, Sachs D.H., Sykes M. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med. 172:1990;195-202.
43. Mayumi H., Good R.A. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide. J Exp Med. 169:1989;213-238.
44. Yang Y.G., deGoma E., Ohdan H., et al. Tolerization of anti-Galα1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med. 187:1998;1335-1342.
45. Abe M., Qi J., Sykes M., Yang Y.G. Mixed chimerism induces donor-specific T cell tolerance across a highly disparate xenogeneic barrier. Blood. 99:2002;3823-3829.
46. Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 183:1996;1797-1806.
47. Lee L.A., Sergio J.J., Sykes M. Evidence for non-immune mechanisms in the loss of hematopoietic chimerism in rat×mouse mixed xenogeneic chimeras. Xenotransplantation. 2:1995;57-66.
48. Gritsch H.A., Sykes M. Host marrow has a competitive advantage which limits donor hematopoietic repopulation in mixed xenogeneic chimeras. Xenotransplantation. 3:1996;312-320.